Skip to content

Cortisol Enhanced Luminescence Assay Kit

by Amersham Corp. 510(k)

Active United States

510(k) K880687

Overview

The Cortisol Enhanced Luminescence Assay Kit is a Class II in vitro diagnostic device designed for the quantitative measurement of cortisol levels in biological samples. It operates as a radioimmunoassay, utilizing radiolabeled antigens and specific antibody binding to determine cortisol concentration. The kit is intended for use in clinical chemistry settings to support endocrine function assessment.

This device is supplied as a complete assay kit and is intended for single-use applications in laboratory environments. It is regulated under FDA product code CGR and was cleared via the 510(k) premarket notification pathway under number K880687. The kit must be stored under specified conditions as outlined by the manufacturer and is subject to special controls applicable to Class II radioimmunoassay devices.

AI-generated from registry data, 26 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK880687 Date24 Mar 1988ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CGR
Device Class
Class II
Regulation
21 CFR Part 862.1205
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Amersham Corp.

See all devices from Amersham Corp. →

Questions

  • What is the Cortisol Enhanced Luminescence Assay Kit used for?

    It is an in vitro diagnostic device used for the quantitative measurement of cortisol levels in biological samples. It supports endocrine function assessment in clinical chemistry settings by utilizing radiolabeled antigens and specific antibody binding.

  • How is the kit supplied and intended for use?

    The device is supplied as a complete assay kit. It is intended for single-use applications in laboratory environments and is not designed for reuse or multi-patient testing scenarios.

  • What are the storage requirements for this assay kit?

    The kit must be stored under specified conditions as outlined by the manufacturer. These conditions are critical to maintaining the integrity of the radiolabeled components and antibody reagents.

  • Is this device regulated as a radioimmunoassay?

    Yes, it is regulated under FDA product code CGR and is subject to special controls applicable to Class II radioimmunoassay devices. Its regulatory classification reflects its use of radioactive materials in diagnostic testing.